Status:
UNKNOWN
Levosimendan Versus Dobutamine in Shock Patients
Lead Sponsor:
Wentworth Area Health Services
Collaborating Sponsors:
Abbott
Conditions:
Cardiogenic Shock
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).
Eligibility Criteria
Inclusion
- Reduced left ventricular systolic function
- Hypotension
- Anuria or oligouria
Exclusion
- Less than 18 years old
- Pregnant
- Uncorrected valvular stenosis
- Hypertrophic obstructive cardiomyopathy (HOCM)
- Third degree AV block
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00093301
Start Date
October 1 2004
End Date
April 1 2006
Last Update
June 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Unit, Nepean Hospital
Penrith, New South Wales, Australia, 2750